Results of a global phase II study with crizotinib in advanced ALK-positive non-small cell lung cancer (NSCLC) Meeting Abstract
| Authors: | Kim, D. W.; Ahn, M. J.; Shi, Y.; De Pas, T. M.; Yang, P. C.; Riely, G. J.; Crino, L.; Evans, T. L.; Liu, X.; Han, J. Y.; Salgia, R.; Moro-Sibilot, D.; Ou, S. H. I.; Gettinger, S. N.; Wu, Y. L.; Lanzalone, S.; Polli, A.; Iyer, S.; Shaw, A. T. |
| Abstract Title: | Results of a global phase II study with crizotinib in advanced ALK-positive non-small cell lung cancer (NSCLC) |
| Meeting Title: | 48th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 30 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2012 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2012-05-20 |
| Language: | English |
| ACCESSION: | WOS:000318009804120 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2012.30.15_suppl.7533 |
| Notes: | Meeting Abstract: 7533 -- Source: Wos |
